» Articles » PMID: 34083494

APOBEC1 Mediated C-to-U RNA Editing: Target Sequence and Trans-acting Factor Contribution to 177 RNA Editing Events in 119 Murine Transcripts In-vivo

Overview
Journal RNA
Specialty Molecular Biology
Date 2021 Jun 4
PMID 34083494
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Mammalian C-to-U RNA editing was described more than 30 years ago as a single nucleotide modification in small intestinal Apob RNA, later shown to be mediated by the RNA-specific cytidine deaminase APOBEC1. Reports of other examples of C-to-U RNA editing, coupled with the advent of genome-wide transcriptome sequencing, identified an expanded range of APOBEC1 targets. Here we analyze the cis-acting regulatory components of verified murine C-to-U RNA editing targets, including nearest neighbor as well as flanking sequence requirements and folding predictions. RNA secondary structure of the editing cassette was associated with editing frequency and exhibited minimal free energy values comparable to small nuclear RNAs. We summarize findings demonstrating the relative importance of trans-acting factors (A1CF, RBM47) acting in concert with APOBEC1. Co-factor dominance was associated with editing frequency, with RNAs targeted by both RBM47 and A1CF edited at a lower frequency than RBM47 dominant targets. Using this information, we developed a multivariable linear regression model to predict APOBEC1 dependent C-to-U RNA editing efficiency, incorporating factors independently associated with editing frequencies based on 103 Sanger-confirmed editing sites, which accounted for 84% of the observed variance. This model also predicted a composite score for available human C-to-U RNA targets, which again correlated with editing frequency.

Citing Articles

Revealing the hidden RBP-RNA interactions with RNA modification enzyme-based strategies.

Jin H, Li C, Jia Y, Qi Y, Piao W Wiley Interdiscip Rev RNA. 2024; 15(3):e1863.

PMID: 39392204 PMC: 11469752. DOI: 10.1002/wrna.1863.


RNA editing enzymes: structure, biological functions and applications.

Zhang D, Zhu L, Gao Y, Wang Y, Li P Cell Biosci. 2024; 14(1):34.

PMID: 38493171 PMC: 10944622. DOI: 10.1186/s13578-024-01216-6.


APOBEC-1 deletion enhances cisplatin-induced acute kidney injury.

Guo X, Blanc V, Davidson N, Velazquez H, Chen T, Moledina D Sci Rep. 2023; 13(1):22255.

PMID: 38097707 PMC: 10721635. DOI: 10.1038/s41598-023-49575-3.


Identification of RNA-Binding Protein Targets with HyperTRIBE in .

Piao W, Li C, Sun P, Yang M, Ding Y, Song W Int J Mol Sci. 2023; 24(10).

PMID: 37240377 PMC: 10218906. DOI: 10.3390/ijms24109033.


RBM47 regulates intestinal injury and tumorigenesis by modifying proliferation, oxidative response, and inflammatory pathways.

Soleymanjahi S, Blanc V, Molitor E, Alvarado D, Xie Y, Gazit V JCI Insight. 2023; 8(9).

PMID: 37014710 PMC: 10243830. DOI: 10.1172/jci.insight.161118.


References
1.
Roberts S, Lawrence M, Klimczak L, Grimm S, Fargo D, Stojanov P . An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat Genet. 2013; 45(9):970-6. PMC: 3789062. DOI: 10.1038/ng.2702. View

2.
Hersberger M, Innerarity T . Two efficiency elements flanking the editing site of cytidine 6666 in the apolipoprotein B mRNA support mooring-dependent editing. J Biol Chem. 1998; 273(16):9435-42. DOI: 10.1074/jbc.273.16.9435. View

3.
Blanc V, Xie Y, Kennedy S, Riordan J, Rubin D, Madison B . Apobec1 complementation factor (A1CF) and RBM47 interact in tissue-specific regulation of C to U RNA editing in mouse intestine and liver. RNA. 2018; 25(1):70-81. PMC: 6298562. DOI: 10.1261/rna.068395.118. View

4.
Hersberger M, Arnold K, Innerarity T . Phylogenetic analysis of the apolipoprotein B mRNA-editing region. Evidence for a secondary structure between the mooring sequence and the 3' efficiency element. J Biol Chem. 1999; 274(49):34590-7. DOI: 10.1074/jbc.274.49.34590. View

5.
Bahn J, Lee J, Li G, Greer C, Peng G, Xiao X . Accurate identification of A-to-I RNA editing in human by transcriptome sequencing. Genome Res. 2011; 22(1):142-50. PMC: 3246201. DOI: 10.1101/gr.124107.111. View